Successful haploidentical hematopoietic stem cell transplantation (HSCT) and durable engraftment by repeated donor lymphocyte infusions for a Chinese patient with transfusion-dependent hemoglobin (Hb) Hammersmith and massive splenomegaly [0.03%]
单倍型相合造血干细胞移植联合多次供者淋巴细胞输注治疗一例依赖输血的汉弥尔兹氏贫血合并巨脾患者
Wilson Y K Chan,Nelson C N Chan,Jason C C So et al.
Wilson Y K Chan et al.
Background: Hemoglobin (Hb) Hammersmith is a rare form of unstable β-chain hemoglobinopathy causing hemolytic anemia. This rare event led to a more serious transfusion-dependent phenotype in a patient. It was successfull...
Case Reports
Pediatric transplantation. 2022 Aug;26(5):e14278. DOI:10.1111/petr.14278 2022
Accuracy of noninvasive fibrosis scores in predicting advanced fibrosis in pediatric patients after liver transplantation [0.03%]
非侵入性肝纤维化评分预测儿童肝移植术后进展期肝纤维化的准确性
Nawras Habash,Yamen Ezaizi,Ibrahim Kak et al.
Nawras Habash et al.
Background: Liver biopsy is the gold standard to stage fibrosis in liver disease. Several scoring systems have been studied to predict advanced fibrosis in liver disease. Those scores have not been validated in pediatric ...
Initial attendance and retention in adult healthcare as criteria for transition success among organ transplant recipients [0.03%]
器官移植受者成人医疗初次就诊和保留作为过渡成功标准的评判标准
Kelly E Rea,Grace K Cushman,Lauren F Quast et al.
Kelly E Rea et al.
Background: Adolescent and young adult (AYA) solid organ transplant recipients experience worsening medical outcomes during transition to adult healthcare. Current understanding and definitions of transition success empha...
Role of therapeutic drug monitoring of intravenous Busulfan for prevention of sinusoidal obstructive syndrome in children [0.03%]
静脉注射Busulfan治疗中监测药物浓度预防儿童肝小静脉闭塞病的作用
Dilek Gurlek Gokcebay,Ozlem Arman Bilir,Seda Şahin et al.
Dilek Gurlek Gokcebay et al.
Background: Therapeutic drug monitoring (TDM) of intravenous busulfan (Bu) has been recommended for safe engraftment and decreased toxicity in children undergoing hematopoietic stem cell transplantation (HSCT). This study...
Necrotizing enterovirus myositis in a pediatric renal transplant recipient [0.03%]
一名儿童肾移植受者的坏死性肠病毒肌炎
Kristen G Valencia Deray,Margaret G Taylor,Melissa M Blessing et al.
Kristen G Valencia Deray et al.
Background: Enteroviruses can cause severe infections, including viral myocarditis, meningitis, acute flaccid myelitis, and viral myositis. Methods/result...
Case Reports
Pediatric transplantation. 2022 Aug;26(5):e14275. DOI:10.1111/petr.14275 2022
Hospitalization following pediatric kidney transplantation: An international comparison among a Canadian pediatric transplant center, North American Pediatric Renal Trials and Collaborative Studies, and Cooperative European Pediatric Renal Transplant Initiative registry data [0.03%]
儿童肾移植后的住院情况：加拿大儿科移植中心、北美儿科肾脏试验与协作研究组和合作欧洲儿科肾脏移植计划注册数据的国际比较
Jin K Kim,Armando J Lorenzo,Burkhard Tönshoff et al.
Jin K Kim et al.
Background: There are several databases across the world that collect pediatric KT data. We compare the hospitalization outcomes for pediatric KT recipients from a large Canadian transplant center (SickKids database; The ...
Alyssa Power,Áine Lynch,Laura Zahavich et al.
Alyssa Power et al.
Introduction: Brugada syndrome is an inherited channelopathy characterized by arrhythmia and an increased risk of sudden cardiac death (SCD). Implantation of a defibrillator for primary or secondary prevention is the only...
Case Reports
Pediatric transplantation. 2022 Aug;26(5):e14276. DOI:10.1111/petr.14276 2022
Use of a donor-derived cell-free DNA assay to monitor treatment response in pediatric renal transplant recipients with allograft rejection [0.03%]
用于监测儿童肾移植受者移植物排斥反应治疗反应的供体衍生无细胞DNA检测的应用
Justin A Steggerda,Helen Pizzo,Jonathan Garrison et al.
Justin A Steggerda et al.
Background: Detection of donor-derived cell-free DNA (dd-cfDNA) reliably identifies allograft rejection in pediatric and adult kidney transplant (KT) recipients. Here, we evaluate the utility of dd-cfDNA for monitoring re...
Responsiveness to second and third dose of mRNA COVID-19 vaccination in adolescent and young adult heart transplant recipients [0.03%]
青少年和年轻成人心脏移植受者对第二次和第三次mRNA新冠疫苗接种的反应性
Brian Feingold,Pamela Berman,Allison Moninger et al.
Brian Feingold et al.
Background: Third-dose mRNA COVID-19 vaccine is currently recommended in the United States for SOT recipients based in part on data showing diminished immune response, including Ab production, after a two-dose regimen. Da...